With malaria one of the biggest killers of children under 5, the world’s first vaccine against a parasite is a major breakthrough for child health

UNICEF has awarded a contract for the first ever supply of a malaria vaccine to GSK with a value of up to USD 170 million[1]. The landmark award will lead to 18 million doses of RTS,S/AS01 (RTS,S) being available over the next three years, potentially saving thousands of lives every year.

Details at: https://www.unicef.org/press-releases/millions-more-children-benefit-malaria-vaccine-unicef-secures-supply